CA2515663C - Systeme de transport a base de chitosane - Google Patents

Systeme de transport a base de chitosane Download PDF

Info

Publication number
CA2515663C
CA2515663C CA 2515663 CA2515663A CA2515663C CA 2515663 C CA2515663 C CA 2515663C CA 2515663 CA2515663 CA 2515663 CA 2515663 A CA2515663 A CA 2515663A CA 2515663 C CA2515663 C CA 2515663C
Authority
CA
Canada
Prior art keywords
transport system
chitosan
several
chitin
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2515663
Other languages
English (en)
Other versions
CA2515663A1 (fr
Inventor
Katja Heppe
Andreas Heppe
Reinhard Schliebs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEPPE MEDICAL CHITOSAN GmbH
Original Assignee
HEPPE MEDICAL CHITOSAN GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102004040243A external-priority patent/DE102004040243A1/de
Application filed by HEPPE MEDICAL CHITOSAN GmbH filed Critical HEPPE MEDICAL CHITOSAN GmbH
Publication of CA2515663A1 publication Critical patent/CA2515663A1/fr
Application granted granted Critical
Publication of CA2515663C publication Critical patent/CA2515663C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA 2515663 2004-08-13 2005-08-11 Systeme de transport a base de chitosane Expired - Fee Related CA2515663C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004040243.4 2004-08-13
DE102004040243A DE102004040243A1 (de) 2003-08-22 2004-08-13 Transportsystem auf Chitosanbasis

Publications (2)

Publication Number Publication Date
CA2515663A1 CA2515663A1 (fr) 2006-02-13
CA2515663C true CA2515663C (fr) 2011-10-18

Family

ID=35852089

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2515663 Expired - Fee Related CA2515663C (fr) 2004-08-13 2005-08-11 Systeme de transport a base de chitosane

Country Status (1)

Country Link
CA (1) CA2515663C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689106B (zh) * 2016-04-26 2023-01-24 微而广治疗有限公司 治疗虾类病毒感染的组合物和方法

Also Published As

Publication number Publication date
CA2515663A1 (fr) 2006-02-13

Similar Documents

Publication Publication Date Title
US20060051423A1 (en) Chitosan-based transport system
Liu et al. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
Rizvi et al. Applications of nanoparticle systems in drug delivery technology
US20210338593A1 (en) Multistage delivery of active agents
Lin et al. GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy
Li et al. Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy
Zhang et al. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration
EP1423095B1 (fr) Particules de glycosaminoglycane lipidees et utilisation de celles-ci dans l'apport de medicament et de gene a des fins de diagnostic et de therapie
Allawadhi et al. Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis
Tan et al. Doxorubicin delivery systems based on chitosan for cancer therapy
Song et al. Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery
Raval et al. Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities
Fang et al. SN38-loaded< 100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
Dangi et al. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles
Su et al. Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy
CN101325947A (zh) 脂质体组合物
Patel et al. Development and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker
Yang et al. Doxorubicin and edelfosine combo-loaded lipid–polymer hybrid nanoparticles for synergistic anticancer effect against drug-resistant osteosarcoma
Li et al. Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo
Ismail et al. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications
Demirtürk et al. Nanocarriers targeting the diseases of the pancreas
Tariq et al. Nanogel-Based transdermal drug delivery system: A therapeutic strategy with under discussed potential
Carissimi et al. Nanoparticles as drug delivery systems
CA2515663C (fr) Systeme de transport a base de chitosane
Ranney et al. Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150811